Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

King TE et al. - The authors cannot recommend treatment with interferon gamma-1b since the drug did not improve survival for patients with idiopathic pulmonary fibrosis, which refutes previous findings from subgroup analyses of survival in studies of patients with mild-to-moderate physiological impairment of pulmonary function.

Related Articles

Tumor necrosis factor inhibitors and lung disease: A paradox of efficacy and risk
Seminars in Arthritis and Rheumatism, 11/20/09    Relevance Score: 68%

Targeted Injury of Type II Alveolar Epithelial Cells Induces Pulmonary Fibrosis
American Journal of Respiratory and Critical Care Medicine, 10/28/09    Relevance Score: 68%

Evaluation of recently validated non- invasive formula using basic lung functions as new screening tool for pulmonary hypertension in idiopathic pulmonary fibrosis patients
Annals of Thoracic Medicine, 10/02/09    Relevance Score: 68%

The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis
Journal of Leukocyte Biology, 11/11/09    Relevance Score: 67%

Pulmonary nocardiosis in cystic fibrosis
Journal of Cystic Fibrosis, 10/07/09    Relevance Score: 67%

Today in Pulmonology...keeping you current

Divalproex Sodium-Induced Eosinophilic Pleural Effusion
American Journal of Therapeutics, 12/04/09

The Aging Lung and Chronic Obstructive Pulmonary Disease
Proceedings of the American Thoracic Society, 12/04/09

Obstructive Sleep Apnea Management with Interactive Computer Technology and Nutrition: Two Case Reports
Journal of Alternative and Complementary Medicine, 12/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address